Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Genitourinary 1

Conditions

Prostatic Neoplasms 4 Urinary Bladder Neoplasms 2 Acute Kidney Injury 2 Spinal Cord Injuries 1 Salivary Gland Adenoma, Pleomorphic 1 Renal Insufficiency 1 Prostatic Hyperplasia 1 Neoplasms 1 Kidney Neoplasms 1 Disease 1

Interventions

pembrolizumab 28 Docetaxel 21 Gemcitabine 19 Nivolumab 15 Paclitaxel 13 Prednisone 12 Leuprolide 11 pazopanib 10 Radiotherapy 10 Cisplatin 10 Sunitinib 9 Sorafenib 9 Ipilimumab 8 Blood Specimen Collection 8 Bevacizumab 8 avelumab 7 atezolizumab 7 Therapeutics 7 Thalidomide 7 Cyclophosphamide 7 Carboplatin 7 Standard of Care 6 Radiation 6 Mitomycin 6 Interleukin-2 6 Cetuximab 6 Axitinib 6 padeliporfin 5 enzalutamide 5 cemiplimab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Urination × Genitourinary × Clear all

NCT04442516 2024-04-17

ACCENT

The Hospital for Sick Children

Neoplasms, Acute Kidney Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡